Derivation and validation of a cardiovascular risk score for prediction of major acute cardiovascular events in non-alcoholic fatty liver disease; the importance of an elevated mean platelet volume.
Robin D AbelesBenjamin Harvey MullishRoberta ForlanoTorben KimhoferMaciej AdlerAlexandros TzallasNikolaos GiannakeasMichael YeeJamil MayetRobert D GoldinMark R ThurszPinelopi ManousouPublished in: Alimentary pharmacology & therapeutics (2019)
The NAFLD CV risk score and MPV accurately predict 1-year risk of MACE, thereby allowing better identification of patients that require optimisation of their cardiovascular risk profile.
Keyphrases